Imbimbo, B P <br/><br/>
A 6-month, double-blind, placebo-controlled trial of eptastigmine in Alzheimer's disease.  [electronic resource] 

 -  Dementia and geriatric cognitive disorders   
 - 17-24 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1420-8008 
<br/><br/><label>Standard No.: </label>10.1159/000017208  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Alzheimer Disease--diagnosis<br/>Cholinesterase Inhibitors--administration & dosage<br/>Dose-Response Relationship, Drug<br/>Double-Blind Method<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Male<br/>Middle Aged<br/>Neuropsychological Tests<br/>Physostigmine--administration & dosage<br/>Treatment Outcome